Zurich Cantonal Bank’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $747K | Buy |
23,866
+4,910
| +26% | +$154K | ﹤0.01% | 1410 |
|
|
2025
Q1 | $636K | Sell |
18,956
-318
| -2% | -$10.7K | ﹤0.01% | 1441 |
|
|
2024
Q4 | $756K | Buy |
19,274
+2,866
| +17% | +$112K | ﹤0.01% | 1377 |
|
|
2024
Q3 | $646K | Sell |
16,408
-8
| -0% | -$315 | ﹤0.01% | 1391 |
|
|
2024
Q2 | $640K | Sell |
16,416
-14,864
| -48% | -$580K | ﹤0.01% | 1315 |
|
|
2024
Q1 | $1.35M | Buy |
31,280
+15,696
| +101% | +$676K | ﹤0.01% | 914 |
|
|
2023
Q4 | $718K | Buy |
15,584
+3,961
| +34% | +$182K | ﹤0.01% | 1256 |
|
|
2023
Q3 | $397K | Buy |
11,623
+2,430
| +26% | +$83K | ﹤0.01% | 1533 |
|
|
2023
Q2 | $354K | Sell |
9,193
-114
| -1% | -$4.39K | ﹤0.01% | 1560 |
|
|
2023
Q1 | $333K | Sell |
9,307
-132
| -1% | -$4.72K | ﹤0.01% | 1549 |
|
|
2022
Q4 | $372K | Buy |
9,439
+2,772
| +42% | +$109K | ﹤0.01% | 1425 |
|
|
2022
Q3 | $241K | Hold |
6,667
| – | – | ﹤0.01% | 1635 |
|
|
2022
Q2 | $203K | Sell |
6,667
-66
| -1% | -$2.01K | ﹤0.01% | 1784 |
|
|
2022
Q1 | $206K | Sell |
6,733
-2,832
| -30% | -$86.6K | ﹤0.01% | 1863 |
|
|
2021
Q4 | $299K | Buy |
9,565
+5,364
| +128% | +$168K | ﹤0.01% | 1812 |
|
|
2021
Q3 | $64K | Buy |
4,201
+110
| +3% | +$1.68K | ﹤0.01% | 2546 |
|
|
2021
Q2 | $76K | Hold |
4,091
| – | – | ﹤0.01% | 2331 |
|
|
2021
Q1 | $73K | Buy |
+4,091
| New | +$73K | ﹤0.01% | 2280 |
|